NCT06734624View on ClinicalTrials.gov

The Microbiome in Blood Cancer and HLH

Not yet recruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2039

Study Completion Date

December 31, 2044

Conditions
Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Haemophagocytic Lymphohistiocytosis
Trial Locations (1)

NG7 2RD

University of Nottingham, Nottingham

All Listed Sponsors
collaborator

Nottingham University Hospitals NHS Trust

OTHER

lead

University of Nottingham

OTHER

NCT06734624 - The Microbiome in Blood Cancer and HLH | Biotech Hunter | Biotech Hunter